CIBC Private Wealth Group’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
EAM
ACG
JMFC
CIBC Private Wealth Group's DNA Position: Q4 2025 in Review
CIBC Private Wealth Group held its Ginkgo Bioworks (DNA) position steady in Q4 2025 at 75 shares worth $623. The position accounts for ﹤0.01% of the portfolio, ranked #3002.
CIBC Private Wealth Group first reported a position in DNA in Q1 2024 and has held it in 8 quarters since. The position peaked at $7.3K in Q1 2024. 180 funds tracked by Wall St. Rank hold DNA as of Q4 2025.
- CIBC Private Wealth Group held 75 shares of Ginkgo Bioworks worth $623 as of Q4 2025.
- CIBC Private Wealth Group left its Ginkgo Bioworks share count unchanged in Q4 2025.
- Ginkgo Bioworks made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #3002 holding.
- CIBC Private Wealth Group first reported a position in Ginkgo Bioworks in Q1 2024 and has held it in 8 quarters since.
- CIBC Private Wealth Group's Ginkgo Bioworks position peaked at $7.3K in Q1 2024.
- 180 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2025.
Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.